The content is available as a PDF (422.9 KB).
. 2021 Sep 20;53:S117–S118. doi: 10.1016/S1590-8658(21)00526-0
OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
F Ferretti
, R Cannatelli
, MC Monico
, AM Carvalhas Gabrielli
, S Carmagnola
, G Maconi
, S Ardizzone
F Ferretti
Find articles by F Ferretti
R Cannatelli
Find articles by R Cannatelli
MC Monico
Find articles by MC Monico
AM Carvalhas Gabrielli
Find articles by AM Carvalhas Gabrielli
S Carmagnola
Find articles by S Carmagnola
G Maconi
Find articles by G Maconi
S Ardizzone
Find articles by S Ardizzone
Issue date 2021 Sep.
Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8451187